YOU want to gain in efficiency in your screening

Relevant models are crucial for multi-target and multicellular diseases (e.g. cancer and neurodegenerative diseases).

WE believe in phenotypic screening as the answer

Because phenotypic screening is a global approach on cells and is performed by High Content Screening (HCS)

HCS Pharma is YOUR partner to implement HCS in your drug discovery

According to your needs, we support you or do it for you!

Services

Explain us your requirements and we develop your assays to best meet your needs !

More
Presentation of the French Plan for Genomic Medicine 2025

Team

Want to know who we are ?

More
Presentation of the French Plan for Genomic Medicine 2025

Why HCS ?

To target complex diseases (as cancer and neurodegenerative diseases), more than one target are needed and screening on complex model is recommended.

More
Presentation of the French Plan for Genomic Medicine 2025

Contact Us

A question ? A comment ? Feel free to contact us !

More
Presentation of the French Plan for Genomic Medicine 2025

Our Services

Latest Post

PlanGenomique2025

+HCS &HCA news

18th Aug 2016

More

Presentation of the French Plan for Genomic Medicine 2025

Last month, an ambitious plan was presented in France. The goal is to place genome sequencing at the heart...

comet

+Meeting

13th Jul 2016

More

Cosm’ing 2016, a great meeting for us !

Julian BURSZTYKA participated to the 7th Cosm’ing event, on cosmetic ingredients & biotechnology

DNA-damage-assay

+Our news

12th Jul 2016

More

Automated comet assay for genotoxicity and DNA damage protection analysis

The comet assay is a sensitive, well established technique for quantifying DNA damage in eukaryotic cells.

cholesterol

+Our news

11th Jul 2016

More

Project CHOPIN selected by the French ANR, and we’re in !

HCS Pharma is proud to be a part of the CHOPIN Project (CHolesterol Personalized INnovation). Selected as one of...

Pierre_Jean_Ferron

+Our news

07th Jul 2016

More

Welcome Pierre-Jean as new HCS Pharma study director !

We are very happy to present you Pierre-Jean Ferron, who joined HCS Pharma as a study director, specialized in...

Drapeau_Bretagne

Innovcell3D Project in collaboration with INSERM U991

We are happy to announce that Brittany region continue to help us (article in french) and co-funds one of...

HCS-Pharma_Cosming2016-1

+Meeting

01st Jul 2016

More

Last day in Cosm’ing 2016

If you are in Cosm'ing meeting, don't hesitate to go and discuss with Julian BURSZTYKA, our COO

CelluleMarketing2 - Thumb

HCS Pharma is at Cosm’ing 2016 !

Come at Cosm’ing in Saint-Malo and meet Julian Bursztka, COO of HCS Pharma. Discover all the advantages of using...

comet

Poster – Use of Automated High Content Analysis Applied To Assessment Of Primary DNA Damages With γH2AX and Comet Assays

Quantifying DNA damage is mandatory to assess potential adverse effects of candidate, drugs, molecules or extracts developed in dermo-cosmetic...

Outsourcing research

+HCS &HCA news

21st Jun 2016

More

Drug Discovery Market

A brand new article shows the importance of outsourcing Drug Discovery and so on the growing potential of this...

Expert Opinion on Drug Discovery - Fraietta

+HCS &HCA news

17th Jun 2016

More

New publication of HCS interest in Drug Discovery

Expert opinion on the potential of High Content Screening

IMG_8951

+Our news

13th Jun 2016

More

We were at e-health event by L’Usine Digital !

We were pleased to talk at e-health day organised in Paris by L'Usine Digital. Our intervention was focused on...

HCSPharma-Galderma

+Our news

07th Jun 2016

More

Genotoxicity assay development in collaboration with Galderma R&D

During ELRIGfr event in Rennes, We had the opportunity to present our work on genotoxicity assay (comet assay on...

Development of a ECM

+HCS &HCA news

03rd Jun 2016

More

Some news in the development of 3D models for biological use

Biosynthetic skeleton for ECM development.

Elrigfr-1634

Feed-back of ELRIGfr Rennes 2016

140 people attented the previous ELRIGfr event in Rennes, co-organized by ELRIGfr and HCS Pharma

adebiotech

+Meeting

28th May 2016

More

StressOX event

HCS Pharma will be present at the stressOX event, organised by Adebiotech at Biocitech

Liszewski_iStock_000089654311_Bioreactor1471062423

+HCS &HCA news

26th May 2016

More

Issues in producing synthetic culture mediums

Interest of synthetic culture mediums for cell cultures and production...

Cosm'ing

Only one month remaining before Cosm’ing !

Let’s discover how High Content Screening can boost your research (An example with an early toxicity assay)

REB

+Our news

19th May 2016

More

We join the “Réseau Entreprendre” circle of laureates

We are very pleased to be distinguished by "Réseau Entreprendre Bretagne" and to enter the circle of laureates.

Poster - Neurotoxicity assay using High Content Screening technology

Poster – Neurotoxicity assay using High Content Screening technology

As shown by AstraZeneca in nature reviews, one third of the safety failures is linked to CNS toxicity during...